Three-dimensional culture systems in cancer research: Focus on tumor spheroid model S Nath, GR Devi Pharmacology & therapeutics 163, 94-108, 2016 | 907 | 2016 |
MUC1: a multifaceted oncoprotein with a key role in cancer progression S Nath, P Mukherjee Trends in molecular medicine 20 (6), 332-342, 2014 | 808 | 2014 |
MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition LD Roy, M Sahraei, DB Subramani, D Besmer, S Nath, TL Tinder, E Bajaj, ... Oncogene 30 (12), 1449-1459, 2011 | 315 | 2011 |
MUC1 induces drug resistance in pancreatic cancer cells via upregulation of multidrug resistance genes S Nath, K Daneshvar, LD Roy, P Grover, A Kidiyoor, L Mosley, M Sahraei, ... Oncogenesis 2 (6), e51-e51, 2013 | 189 | 2013 |
MUC1 regulates PDGFA expression during pancreatic cancer progression M Sahraei, LD Roy, JM Curry, TL Teresa, S Nath, D Besmer, A Kidiyoor, ... Oncogene 31 (47), 4935-4945, 2012 | 100 | 2012 |
X-linked inhibitor of apoptosis protein mediates tumor cell resistance to antibody-dependent cellular cytotoxicity MK Evans, SJ Sauer, S Nath, TJ Robinson, MA Morse, GR Devi Cell death & disease 7 (1), e2073-e2073, 2016 | 60 | 2016 |
Mucin 1 regulates Cox-2 gene in pancreatic cancer S Nath, LD Roy, P Grover, S Rao, P Mukherjee Pancreas 44 (6), 909-917, 2015 | 44 | 2015 |
SMAD4-independent activation of TGF-β signaling by MUC1 in a human pancreatic cancer cell line P Grover, S Nath, MD Nye, R Zhou, M Ahmad, P Mukherjee Oncotarget 9 (6), 6897, 2018 | 35 | 2018 |
MicroRNA miR-308 regulates dMyc through a negative feedback loop in Drosophila K Daneshvar, S Nath, A Khan, W Shover, C Richardson, JM Goodliffe Biology Open 2 (1), 1-9, 2012 | 24 | 2012 |
Pancreatic cancer cells isolated from Muc1-null tumors favor the generation of a mature less suppressive MDSC population A Kidiyoor, J Schettini, DM Besmer, SL Rego, S Nath, JM Curry, LD Roy, ... Frontiers in Immunology 5, 67, 2014 | 20 | 2014 |
Repression of MUC1 promotes expansion and suppressive function of myeloid-derived suppressor cells in pancreatic and breast cancer murine models M Sahraei, M Bose, JA Sanders, C De, L DasRoy, S Nath, CR Brouwer, ... International journal of molecular sciences 22 (11), 5587, 2021 | 17 | 2021 |
Overexpression of MUC1 induces non-canonical TGF-β signaling in pancreatic ductal adenocarcinoma M Bose, P Grover, AJ Sanders, R Zhou, M Ahmad, S Shwartz, P Lala, ... Frontiers in cell and developmental biology 10, 821875, 2022 | 15 | 2022 |
Indomethacin enhances anti-tumor efficacy of a MUC1 peptide vaccine against breast cancer in MUC1 transgenic mice JM Curry, DM Besmer, TK Erick, N Steuerwald, L Das Roy, P Grover, ... PLoS One 14 (11), e0224309, 2019 | 15 | 2019 |
P1396: CD33-DELETED HEMATOPOIETIC STEM AND PROGENITOR CELLS DISPLAY NORMAL ENGRAFTMENT AFTER HEMATOPOIETIC CELL TRANSPLANT (HCT) AND TOLERATE POST-HCT GEMTUZUMAB OZOGAMICIN (GO … G Koehne, B Tomlinson, H Suh, D Koura, C Cho, NM Bambace, ... HemaSphere 7 (S3), e24418bc, 2023 | 5 | 2023 |
Trial in Progress: a first-in-human phase 1/2 study of hematopoietic stem cell transplantation (HCT) with VOR33 (CD33-deleted allograft) followed by treatment with gemtuzumab … BW Cooper, HC Suh, D Koura, G Koehne, C Cho, NM Bambace, ... Blood 140 (Supplement 1), 12973-12975, 2022 | 2 | 2022 |
Repression of MUC1 promotes expansion and suppressive function of myeloid-derived suppressor cells in pancreatic ductal adenocarcinoma and breast cancer murine models S Mahnaz, LD Roy, M Bose, C De, S Nath, P Mukherjee bioRxiv, 2020.12. 07.415299, 2020 | 2 | 2020 |
Delivery of Synthetic mRNA Encoding FOXP3 Antigen into Dendritic Cells for Inflammatory Breast Cancer Immunotherapy GR Devi, S Nath Synthetic mRNA: Production, Introduction Into Cells, and Physiological …, 2016 | 2 | 2016 |
Combinational treatment with MUC1 vaccine and Indomethacin reduces breast tumor burden via a COX-independent pathway. JM Curry, DM Besmer, L Das Roy, P Grover, S Nath, S Rao, P Mukherjee Cancer Research 73 (8_Supplement), 475-475, 2013 | 2 | 2013 |
Transcriptional regulation of genes associated with drug resistance and growth of pancreatic cancer cells by mucin 1 S Nath The University of North Carolina at Charlotte, 2013 | 2 | 2013 |
Phase 1/2 Study of Donor-Derived Anti-CD33 Chimeric Antigen Receptor Expressing T Cells (VCAR33) in Patients with Relapsed or Refractory Acute Myeloid Leukemia after Allogeneic … NN Shah, J Azzi, BW Cooper, A Deol, J DiPersio, D Koura, B McClune, ... Blood 142, 4862, 2023 | 1 | 2023 |